| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/08/2007 | WO2007016292A2 Heterocyclic amides as biofilm modulators |
| 02/08/2007 | WO2007015588A1 Piperidine derivative as tachykinin receptor antagonist |
| 02/08/2007 | WO2007015412A1 Heterocyclic compound and organic electroluminescent device using same |
| 02/08/2007 | WO2007015262A2 A process for the preparation of (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl)]piperidine |
| 02/08/2007 | WO2007015162A1 Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds |
| 02/08/2007 | WO2007014885A1 Antibacterial quinoline derivatives |
| 02/08/2007 | WO2007014851A2 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 02/08/2007 | WO2007014619A1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 02/08/2007 | WO2007014412A1 Method for isolating 5-substituted tetrazoles |
| 02/08/2007 | WO2006113704A3 Subtituted heteroaryl cb1 antagonists |
| 02/08/2007 | WO2006071775A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 02/08/2007 | WO2006045119A3 Improved inhibitors for the soluble epoxide hydrolase |
| 02/08/2007 | US20070032664 Making intermediates such as ((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-ethyl}-2-phenyl-[1,3]dioxan-4-yl)-acetic acid methyl ester for the synthesis of calcium atorvastatin (Lipitor(reg)) |
| 02/08/2007 | US20070032663 Intermediate in the synthesis of calcium atorvastatin (Lipitor(reg)) comprising an amine salt of a carboxylic acid, for example 2-(morpholinocarbonyl)ethylamine, phenylacetic acid salt |
| 02/08/2007 | US20070032662 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrole-3-carboxylic acid and phenylamide |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/08/2007 | US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 02/08/2007 | US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia |
| 02/08/2007 | US20070032509 New capped pyrazinoylguanidine sodium channel blockers |
| 02/08/2007 | US20070032497 Fused-ring compounds and use thereof as drugs |
| 02/08/2007 | US20070032490 N-Phenyl-'(4-pyridyl)-azinyl!amine derivatives as plant protection agents |
| 02/08/2007 | US20070032489 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
| 02/08/2007 | US20070032486 5Ht4-antagonistic 4-(aminomethyl)-piperidine benzamides |
| 02/08/2007 | CA2617654A1 Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds |
| 02/08/2007 | CA2617282A1 Novel imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 02/08/2007 | CA2616937A1 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 02/08/2007 | CA2616510A1 Cycloalkyl amino-hydantoin compounds and use thereof for .beta.-secretase modulation |
| 02/08/2007 | CA2615574A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/08/2007 | CA2614981A1 Antibacterial quinoline derivatives |
| 02/07/2007 | EP1749817A1 Neurogenic pain control agent composition |
| 02/07/2007 | EP1749002A1 Pyrrole or imidazole amides for treating obesity |
| 02/07/2007 | EP1749001A1 3-piperidinylisochroman-5-ols as dopamine agonists |
| 02/07/2007 | EP1749000A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
| 02/07/2007 | EP1748995A1 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both |
| 02/07/2007 | EP1748991A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents |
| 02/07/2007 | EP1748989A2 Aryl sulfonamides |
| 02/07/2007 | EP1748987A2 2-propene-1-ones as hsp 70 inducers |
| 02/07/2007 | EP1748984A1 Piperidine derivatives as nk1 and nk3 antagonists |
| 02/07/2007 | EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists |
| 02/07/2007 | EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase |
| 02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/07/2007 | EP1501504B1 1-substituted imidazole derivatives as nos inhibitors |
| 02/07/2007 | EP1017680B1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 02/07/2007 | EP0998474B1 Piperazine derivatives |
| 02/07/2007 | CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 02/07/2007 | CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 02/07/2007 | CN1910159A 2,4-diaminopyrimidines and their use for inducing cardiomyogenesis |
| 02/07/2007 | CN1910151A Cyclic amine derivative with heteroaryl ring |
| 02/07/2007 | CN1909909A 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept |
| 02/07/2007 | CN1909907A Quinoline derivatives and use thereof as mycobacterial inhibitors |
| 02/07/2007 | CN1907985A N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof |
| 02/07/2007 | CN1907984A Compound for preparing intermediate for synthesis of atorvastatin calcium |
| 02/07/2007 | CN1907982A New compounds useful for the treatment of obesity,type II diabetes and CNS disorders |
| 02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
| 02/07/2007 | CN1298714C Process to produce 4-hydroxy-2-oxo-pyrone derivates useful as protease inhibitors |
| 02/07/2007 | CN1298711C Processes for producing epoxytriazole derivative and intermediate therefor |
| 02/07/2007 | CN1298705C Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 02/06/2007 | US7173136 3-Cyano-quinoline derivatives |
| 02/06/2007 | US7173135 Substituted 3-cyanoquinolines as MEK inhibitors |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173133 cCs-rac-4-phenyl-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one; treating diseases related to activation of NMDA receptors via Glyt-1 inhibition |
| 02/06/2007 | US7173129 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 02/06/2007 | US7173128 Benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole derivatives; polymer and photographic stabilizers |
| 02/06/2007 | US7173054 Respiratory syncytial virus replication inhibitors |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173039 Compounds that modulate or inhibit enzymes for occular diseases |
| 02/06/2007 | US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 02/06/2007 | US7173034 Drugs for treatment of viral diseases such as Respiratory syncytial virus |
| 02/06/2007 | US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 02/06/2007 | US7173028 Pyrimidine derivatives |
| 02/06/2007 | CA2214320C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 02/01/2007 | WO2007014198A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders |
| 02/01/2007 | WO2007013694A1 Phenoxyalkanoic acid compound |
| 02/01/2007 | WO2007013421A1 Novel nitrogenated heterocyclic compound |
| 02/01/2007 | WO2007012900A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/01/2007 | WO2006129120A3 Benzotriazepinone derivatives |
| 02/01/2007 | WO2005112919A3 Self-immolative linkers and drug conjugates |
| 02/01/2007 | WO2005090329A9 New compounds for the inhibition of angiogenesis and use of thereof |
| 02/01/2007 | US20070027321 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 02/01/2007 | US20070027310 Novel ligands and methods for preparing same |
| 02/01/2007 | US20070027196 Activator of peroxisome proliferator-activated receptor delta |
| 02/01/2007 | US20070027190 Antibacterial fab i inhibitors |
| 02/01/2007 | US20070027185 inhibitor of factor Xa and/or thrombin; anticoagulantsto treat thromboembolic disorders, myocardial ischemia, myocardial infarction and cerebral thrombosis; N-(5-chloropyridin-2-yl)-3-[2-(piperidin-4-yloxy)-4-(pyrrolidin-1-yl)benzoylamino]pyridine-4-carboxamide; high bioavailability; acylation |
| 02/01/2007 | US20070027174 Phenylalanine Enamide Derivatives |
| 02/01/2007 | US20070027170 Process for preparing amino crotonyl compounds |
| 02/01/2007 | US20070027162 Crystalline and amorphous 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin -1-yl]-propyl}-N-pyridin-2-yl-benzamide hydrochloride |
| 02/01/2007 | US20070027159 Therapeutic agents useful for treating pain |
| 02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
| 02/01/2007 | US20070027126 E.g., N-[4-(5-cyano-1-methyl-1H-pyrrol-2-yl)phenyl]propane-1-sulfonamide and tert-butyl 2-cyano-5-{4-{(ethylsulfonyl)amino]phenyl}-1H-pyrrole-1-carboxylate; useful for contraception and hormone replacement therapy |
| 02/01/2007 | US20070027125 Cyanopyrrole-phenyl progesterone receptor modulators and uses thereof |
| 02/01/2007 | DE102005035395A1 Preparation of optically active 2,3-diarylepoxide compounds comprises epoxidizing diaryl compounds and optionally separating the obtained enantiomeric mixture |
| 02/01/2007 | DE102005034264A1 4-Chromenonyl-1,4-dihydropyridincarbonitrile und ihre Verwendung 4-Chromenonyl-1,4-dihydropyridincarbonitrile and their use |
| 02/01/2007 | CA2616547A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/01/2007 | CA2614919A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders |
| 01/31/2007 | EP1748045A1 Light-emitting device material and light-emitting device |
| 01/31/2007 | EP1747210A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 01/31/2007 | EP1747206A1 Amino-tetrazoles analogues and methods of use |
| 01/31/2007 | EP1747204A1 Tri-substituted ureas as cytokine inhibitors |